Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine M Forbes

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
The American Journal of Pathology|September 4, 2010
The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the keyJosephine M Forbes
Kidney International|April 26, 2020
Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?Josephine M Forbes
Trends in Endocrinology and Metabolism: TEM|May 25, 2016
Mitochondria-Power Players in Kidney Function?Josephine M Forbes
Glycoconjugate Journal|June 9, 2016
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?Aowen Zhuang, Josephine M Forbes
Protein and Peptide Letters|May 14, 2008
Advanced glycation: implications in tissue damage and diseaseAnna Gasser, Josephine M Forbes
The Journal of Endocrinology|July 2, 2014
Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy?Aowen Zhuang, Josephine M Forbes
American Journal of Nephrology|June 10, 2011
Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetesMelinda T Coughlan, Josephine M Forbes
Glycoconjugate Journal|July 10, 2016
Targeting advanced glycation with pharmaceutical agents: where are we now?Danielle J Borg, Josephine M Forbes
Physiological Reviews|January 11, 2013
Mechanisms of diabetic complicationsJosephine M Forbes, Mark E Cooper
Kidney International|October 19, 2025
Round and round we go: phosphoenolpyruvate carboxykinase 1 (PCK1) in cataplerosis, mitochondrial, and kidney healthMitchell A Sullivan, Josephine M Forbes
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
The American Journal of Pathology|September 4, 2010
The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the keyJosephine M Forbes
Kidney International|April 26, 2020
Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?Josephine M Forbes
Trends in Endocrinology and Metabolism: TEM|May 25, 2016
Mitochondria-Power Players in Kidney Function?Josephine M Forbes
Glycoconjugate Journal|June 9, 2016
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?Aowen Zhuang, Josephine M Forbes
Protein and Peptide Letters|May 14, 2008
Advanced glycation: implications in tissue damage and diseaseAnna Gasser, Josephine M Forbes
The Journal of Endocrinology|July 2, 2014
Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy?Aowen Zhuang, Josephine M Forbes
American Journal of Nephrology|June 10, 2011
Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetesMelinda T Coughlan, Josephine M Forbes
Glycoconjugate Journal|July 10, 2016
Targeting advanced glycation with pharmaceutical agents: where are we now?Danielle J Borg, Josephine M Forbes
Physiological Reviews|January 11, 2013
Mechanisms of diabetic complicationsJosephine M Forbes, Mark E Cooper
Kidney International|October 19, 2025
Round and round we go: phosphoenolpyruvate carboxykinase 1 (PCK1) in cataplerosis, mitochondrial, and kidney healthMitchell A Sullivan, Josephine M Forbes
Pageof 15